{"id":46618,"date":"2024-05-08T09:25:00","date_gmt":"2024-05-08T09:25:00","guid":{"rendered":"http:\/\/937e13b8cd0b4b0afd740911b107e9ff"},"modified":"2024-11-03T15:11:51","modified_gmt":"2024-11-03T15:11:51","slug":"esmo-breast-cancer-2024-15-17-may-berlin-germany","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/esmo-breast-cancer-2024-15-17-may-berlin-germany\/","title":{"rendered":"ESMO Breast Cancer 2024, 15-17 May, Berlin, Germany"},"content":{"rendered":"<p>Lugano, Switzerland, 8 May 2024 \u2013 ESMO Breast Cancer 2024 will be held in Berlin, Germany, between 15-17 May where the latest research in breast cancer will be presented. Participants from all over the world are expected to come to Berlin to listen to renowned experts presenting key innovative areas \u2013 including new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications \u2013 and providing perspectives on how transformative new data can find a clear path to the clinic.<\/p>\n<p>The congress can be attended in person and online.<\/p>\n<p>The <a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/session\/calendar\/2024-05-16\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">scientific programme<\/a> is already available online.<\/p>\n<h3>Programme highlights<\/h3>\n<ul>\n<li>Novel data on safety of assisted reproductive techniques in patients with BRCA mutation.\n<ul>\n<li>\n<em>Related content: <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/27\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>266O<\/em><\/a>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Encouraging approaches to improve genitourinary symptoms and sexual health in breast cancer survivors.\n<\/li>\n<\/ul>\n<ul>\n<li>Promising new targets for antibody-drug conjugates (ADCs) within the precision medicine landscape.\n<ul>\n<li>\n<em>Related Content: <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/42\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>60P<\/em><\/a><em>, <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/32\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>Session<\/em><\/a><em>&nbsp;on 16 May, 08:30 &#8211; 10:00 CEST<\/em>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>New insights exploring patients\u2019 understanding of biomarkers and biomarkers-based treatment decisions in early and metastatic breast cancer.\n<ul>\n<li>\n<em>Related content: <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/42\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>71P<\/em><\/a><em>, <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/28\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>Session<\/em><\/a><em>&nbsp;on 15 May,16:45 &#8211; 18:15 CEST<\/em>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Findings on the growing application and benefits of artificial intelligence in breast cancer care.\n<ul>\n<li>\n<em>Related content: <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/42\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>65P<\/em><\/a><em>, <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/42\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>66P<\/em><\/a><em>, <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/29\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>Session<\/em><\/a><em>&nbsp;on 17 May, 08:30 &#8211; 10:00 CEST<\/em>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Enriching perspectives on hot topics and areas of unmet need: ctDNA in practice and the management of central nervous system metastases.\n<ul>\n<li>\n<em>Related content: <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/22\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>Session<\/em><\/a><em>&nbsp;on 16 May, 10:30 &#8211; 12:00 CEST; &nbsp;<\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/17\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>Session<\/em><\/a><em>&nbsp;on 17 May, 10:30 &#8211; 12:00 CEST<\/em>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Results of phase 3 studies in:\n<ul>\n<li>Metastatic triple-negative breast cancer \u2013 <em>Related content:<\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/15\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>180O<\/em><\/a>\n<\/li>\n<li>Metastatic and advanced breast cancer \u2013 <em>Related content: <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/27\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>LBA2<\/em><\/a><em>, <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/40\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>182MO<\/em><\/a><em>, <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/40\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>183MO<\/em><\/a>\n<\/li>\n<li>Early breast cancer \u2013 <em>Related content: <\/em><a href=\"https:\/\/cslide.ctimeetingtech.com\/breast24hybrid\/attendee\/confcal\/show\/session\/16\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\"><em>113MO<\/em><\/a>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3>Keynote Lecture<\/h3>\n<p>The results of 279 studies will be presented and published online as a supplement to <em>ESMO Open.<\/em><\/p>\n<h3>Press accreditation<\/h3>\n<p>ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the <a href=\"https:\/\/www.esmo.org\/newsroom\/press-and-media-policies\/esmo-policy-on-press-activities\" class>ESMO Policy on Press Activities<\/a>. To apply for press accreditation, please fill out the form available <a href=\"https:\/\/press-portal.esmo.org\/#\/accreditation?meeting=7787&amp;callbackUrl=https:\/\/www.esmo.org\/newsroom\/esmo-press-office\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">here<\/a>. Requests for press accreditation should be sent by Tuesday, 14 May. Please be kindly informed that onsite press accreditation will not be possible.<\/p>\n<h4><strong>Further information<\/strong><\/h4>\n<p>ESMO Press Office<br \/><a href=\"mailto:press@esmo.org\" target=\"_blank\" rel=\"noopener noreferrer\" class>press@esmo.org<\/a><\/p>\n<h4><strong>Notes to editors<\/strong><\/h4>\n<p>Please make sure to use the official name of the meeting in your reports: <strong>ESMO Breast Cancer 2024<\/strong> and the official congress hashtag <strong>#ESMOBreast24<\/strong>. Follow it to stay up to date and use it to take part in the conversation on <a href=\"https:\/\/twitter.com\/myESMO\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">X (Twitter),<\/a> <a href=\"https:\/\/www.linkedin.com\/company\/481100\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">LinkedIn,<\/a> <a href=\"https:\/\/www.facebook.com\/esmo.org\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Facebook,<\/a> <a href=\"https:\/\/www.instagram.com\/esmo_eur_oncology\/\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Instagram,<\/a> <a href=\"https:\/\/www.youtube.com\/user\/ESMOchannel\/\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">YouTube.<\/a><\/p>\n<p><a href=\"https:\/\/www.esmo.org\/newsroom\/press-and-media-hub\/esmo-media-releases\/esmo-breast-cancer-2024-15-17-may-berlin-germany\">Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Lugano, Switzerland, 8 May 2024 \u2013 ESMO Breast Cancer 2024 will be held in Berlin, Germany, between 15-17 May where the latest research in breast cancer will be presented. Participants from all over the world are expected to come to Berlin to listen to renowned experts presenting key innovative areas \u2013 including new agents, molecular [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-46618","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=46618"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46618\/revisions"}],"predecessor-version":[{"id":47041,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46618\/revisions\/47041"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=46618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=46618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=46618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}